Your independence is worth fighting for.
Intelligence, insights, and resources for independent medical practices navigating corporate consolidation, prior authorization battles, and the AI tools that change the equation.
Private equity and hospital systems aren't acquiring independent practices by force. They're making administrative burden so heavy that selling feels inevitable. Here is how the weapon works — and how to disarm it.
Read article → Independence MissionThey can't force you to sell. So instead, they make staying feel impossible. Here is why your independence is worth fighting for — and the AI built to fight alongside you.
Read article → Independence MissionPrior authorization was designed as a cost control mechanism. Data shows it has become one of the most effective instruments accelerating the consolidation of independent medicine.
Read article → IPA LeadershipThe average independent practice loses over $30,000 annually to denied claims that were never appealed. For IPA leaders, the math across your membership is staggering — and the problem is preventable.
Read article →Prior authorization burden is cited as a top reason physicians sell their practices. That is not a coincidence. Here is the business case corporate consolidators are using — and the AI tools that remove their leverage.
Coming soon79% of independent practice leaders say technology is critical to staying independent. Only 64% are confident in their current tools. That gap is costing practices their autonomy — and MedMojo exists to close it.
Coming soonPrior auth is where the fight starts. Revenue intelligence, payer contract analysis, compliance monitoring, clinical documentation coaching — the complete AI toolkit that makes independent practice not just viable, but superior to selling.
Coming soon420 prior auth requests annually. A 51% denial rate on complex requests. $83,200 in lost revenue per practice per year. Here is the cost of the biologic burden — and how AI fights back.
Read article →Insurance companies have invested hundreds of millions in AI that denies claims faster than any human can respond. Your billing team is fighting an algorithm with paperwork. Here is how to level the playing field.
Coming soonA proper denial appeal letter has six components. Most practices send one vague paragraph. Here is the exact structure that moves insurance reviewers toward approval — and the clinical language that wins.
Coming soonMiss your appeal deadline and the revenue is gone permanently. Here are the exact appeal windows for every major payer — and the alert system that ensures your team never forfeits another claim.
Coming soonWhen a prior auth is denied your physician has the right to speak directly with the insurance company's medical reviewer. Studies show this reverses denials in 30–60% of cases.
Coming soonMost denied appeals fail for the same five reasons. None of them are clinical. All of them are fixable — if you know what insurance reviewers are actually looking for when they evaluate your appeal.
Coming soonEvery biologic prescription — Humira, Enbrel, Remicade — is a prior auth battle. Here is the clinical documentation strategy that wins approvals and reverses denials for rheumatology practices.
Coming soonThe federal government mandated that payers implement FHIR APIs for prior authorization by January 2027. Here is what changes for independent practices — and what the regulation does not fix.
Coming soon